Sign in
8-K

Current Report

PDS Biotechnology Corp Filed Acc 0001140361-26-034320

Exit or restructuring costs · Executive or director change

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading ef20081077_8k.htm…